ESLA

Estrella Immunopharma

• NASDAQ·08/12 05:26

  Estrella Adds Cleveland Site To STARLIGHT-1 Trial For B-cell Lymphoma; Stock Up

• TipRanks·08/11 12:06

  Estrella Immunopharma activates fourth clinical site for STARLIGHT-1 trial

• Benzinga·08/05 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• TipRanks·08/03 12:05

  Estrella Immunopharma activates third trial site for Starlight-1 trial

• Benzinga·08/03 12:05

  Estrella Immunopharma Activates Third Clinical Site For Ongoing STARLIGHT-1 Phase I/II Clinical Trial Evaluating EB103, CD19-Redirected ARTEMIS T-Cell Therapy, In Patients With R/R B-Cell Non-Hodgkin’s Lymphoma

• TipRanks·07/29 12:10

  Estrella Immunopharma activates second clinical site for STARLIGHT-1 trial

• Benzinga·07/29 12:05

  Estrella Immunopharma Activates Second Clinical Facility For Its Current STARLIGHT-1 Phase I/II Clinical Study Of EB103 In Participants With Relapsed Or Refractory B-Cell Non-Hodgkin’s Lymphoma

• TipRanks·07/24 12:05

  Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial

• Benzinga·07/24 12:02

  Estrella Immunopharma Doses First Participant In Its Current STARLIGHT-1 Phase I/II Clinical Study Of EB103 In Patients With Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

• Benzinga·07/17 17:05

  12 Health Care Stocks Moving In Friday's Intraday Session

• Benzinga·07/07 12:05

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·06/30 21:54

  Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment

• Benzinga·05/18 13:57

  Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate

• Press release·05/18 12:11

  Estrella Immunopharma, Inc. Reports Financial Results for the Quarter Ended March 31, 2026

• Benzinga·04/10 21:13

  12 Health Care Stocks Moving In Friday's After-Market Session